US 11814444
Cyclic polypeptides for PCSK9 inhibition
granted A61KA61K38/00A61P
Quick answer
US patent 11814444 (Cyclic polypeptides for PCSK9 inhibition) held by RA PHARMACEUTICALS, INC. expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- RA PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K38/00, A61P, A61P3/06